(Q42687213)

4 November 2017

0 references

The efficacy of sildenafil citrate (Viagra) in clinical populations: an update (English)

1 reference

4 November 2017

Culley C Carson

1

1 reference

4 November 2017

Arthur L Burnett

series ordinal

2

1 reference

4 November 2017

Laurence A Levine

series ordinal

3

1 reference

4 November 2017

Ajay Nehra

series ordinal

4

1 reference

4 November 2017

language of work or name

English

0 references

publication date

1 September 2002

1 reference

4 November 2017

1 reference

4 November 2017

60

1 reference

4 November 2017

12-27

1 reference

4 November 2017

2 Suppl 2

1 reference

NIH Consensus Conference. Impotence. NIH Consensus Development Panel on Impotence

4 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901687-4

7 January 2021

Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901687-4

7 January 2021

Modifiable risk factors and erectile dysfunction: can lifestyle changes modify risk?

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901687-4

7 January 2021

The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901687-4

7 January 2021

Diagnostic evaluation of the erectile function domain of the International Index of Erectile Function.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901687-4

7 January 2021

Treatment of erectile dysfunction with sildenafil.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901687-4

7 January 2021

Clinical efficacy of sildenafil citrate based on etiology and response to prior treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901687-4

7 January 2021

Erectile dysfunction in general medicine practice: prevalence and clinical correlates

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901687-4

7 January 2021

Aging and erectile dysfunction: the role of aging and concomitant chronic illness

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901687-4

7 January 2021

Sildenafil citrate (VIAGRA) improves erectile function in elderly patients with erectile dysfunction: a subgroup analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901687-4

7 January 2021

Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901687-4

7 January 2021

Sildenafil for treatment of erectile dysfunction in men with diabetes: a randomized controlled trial. Sildenafil Diabetes Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901687-4

7 January 2021

Barriers to recognition of erectile dysfunction among diabetic Mexican-American men.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901687-4

7 January 2021

Diabetes and diabetic retinopathy in a Mexican-American population: Proyecto VER

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901687-4

7 January 2021

Risk factors for cardiovascular and cerebrovascular death among African Americans and Hispanics in Los Angeles, California

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901687-4

7 January 2021

Efficacy and safety of sildenafil citrate (Viagra) in black and Hispanic American men.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901687-4

7 January 2021

Body mass index and the prevalence of hypertension and dyslipidemia

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901687-4

7 January 2021

Is obesity an underlying factor in erectile dysfunction?

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901687-4

7 January 2021

Efficacy and safety of sildenafil citrate in the treatment of men with mild to moderate erectile dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901687-4

7 January 2021

Viagra--after one year

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901687-4

7 January 2021

Erectile dysfunction and quality of life in type 2 diabetic patients: a serious problem too often overlooked

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901687-4

7 January 2021

Sildenafil citrate for the treatment of erectile dysfunction in men with Type II diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901687-4

7 January 2021

Efficacy and safety of sildenafil citrate in the treatment of erectile dysfunction in patients with ischemic heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901687-4

7 January 2021

Does severity of ischemic coronary disease correlate with erectile function?

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901687-4

7 January 2021

Management of sexual dysfunction in patients with cardiovascular disease: recommendations of The Princeton Consensus Panel.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901687-4

7 January 2021

Detection of peripheral arterial disease in primary care

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901687-4

7 January 2021

Peripheral arterial disease detection, awareness, and treatment in primary care

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901687-4

7 January 2021

Aortofemoral surgery and sexual function

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901687-4

7 January 2021

Effect of sildenafil in patients with erectile dysfunction taking antihypertensive therapy. Sildenafil Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901687-4

7 January 2021

The epidemiology, anatomy, physiology, and treatment of erectile dysfunction in chronic renal failure patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901687-4

7 January 2021

Preliminary observations of sildenafil treatment for erectile dysfunction in dialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901687-4

7 January 2021

Erectile dysfunction and the effects of sildenafil treatment in patients on haemodialysis and continuous ambulatory peritoneal dialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901687-4

7 January 2021

Treatment with sildenafil citrate in renal transplant patients with erectile dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901687-4

7 January 2021

Transient renal effects of sildenafil in male kidney transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901687-4

7 January 2021

Treatment of erectile dysfunction after radical prostatectomy with sildenafil citrate (Viagra)

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901687-4

7 January 2021

Role of Viagra after radical prostatectomy.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901687-4

7 January 2021

Sildenafil in the treatment of erectile dysfunction after radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901687-4

7 January 2021

Time dependent patient satisfaction with sildenafil for erectile dysfunction (ED) after nerve-sparing radical retropubic prostatectomy (RRP)

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901687-4

7 January 2021

The development of erectile dysfunction in men treated for prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901687-4

7 January 2021

Treatment of erectile dysfunction with sildenafil citrate (Viagra) after radiation therapy for prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901687-4

7 January 2021

Sildenafil citrate (Viagra) and erectile dysfunction following external beam radiotherapy for prostate cancer: a randomized, double-blind, placebo-controlled, cross-over study

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901687-4

7 January 2021

Prospective pilot study of sildenafil for treatment of postradiotherapy erectile dysfunction in patients with prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901687-4

7 January 2021

Sildenafil citrate effectively reverses sexual dysfunction induced by three-dimensional conformal radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901687-4

7 January 2021

Efficacy of oral sildenafil in patients with erectile dysfunction after radiotherapy for carcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901687-4

7 January 2021

Potency after permanent prostate brachytherapy for localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901687-4

7 January 2021

Efficacy of sildenafil citrate in prostate brachytherapy patients with erectile dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901687-4

7 January 2021

A two-part pilot study of sildenafil (VIAGRA) in men with erectile dysfunction caused by spinal cord injury

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901687-4

7 January 2021

Efficacy and safety of oral sildenafil (Viagra) in men with erectile dysfunction caused by spinal cord injury.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901687-4

7 January 2021

Randomized trial of sildenafil for the treatment of erectile dysfunction in spinal cord injury. Sildenafil Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901687-4

7 January 2021

Efficacy, safety and predictive factors of therapeutic success with sildenafil for erectile dysfunction in patients with different spinal cord injuries.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901687-4

7 January 2021

Efficacy and safety of oral sildenafil in men with erectile dysfunction and spinal cord injury.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901687-4

7 January 2021

Efficacy and safety of sildenafil citrate (Viagra) in men with erectile dysfunction and spinal cord injury: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901687-4

7 January 2021

Efficacy of sildenafil citrate for the treatment of erectile dysfunction in men taking serotonin reuptake inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901687-4

7 January 2021

Depression, antidepressant therapies, and erectile dysfunction: clinical trials of sildenafil citrate (Viagra) in treated and untreated patients with depression

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901687-4

7 January 2021

Treatment of erectile dysfunction in men with depressive symptoms: results of a placebo-controlled trial with sildenafil citrate

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901687-4

7 January 2021

Assessment of the efficacy and safety of Viagra (sildenafil citrate) in men with erectile dysfunction during long-term treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901687-4

7 January 2021

Efficacy, safety, and use of sildenafil in urologic practice

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901687-4

7 January 2021

Achieving treatment optimization with sildenafil citrate (Viagra) in patients with erectile dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901687-4

7 January 2021

10.1016/S0090-4295(02)01687-4

Identifiers

DOI

1 reference

4 November 2017

1 reference